Viral Vaccines Market Size & Forecast to 2031
According to a recent publication from Meticulous Research®, the viral vaccines market is expected to reach $47.01 billion by 2031, growing at a CAGR of 1.9% from 2024 to 2031. This market growth is driven by a robust pipeline of new vaccines, increased government emphasis on immunization programs, advancements in vaccine administration technologies, and the use of inactivated vaccines in surgeries and treatments. Additionally, the expansion of biopharmaceutical production capacity, a rising focus on therapeutic vaccines, the increasing use of adjuvants, growth opportunities in emerging markets, and the development of highly stable and energy-efficient ultra-low temperature freezers are anticipated to provide significant growth opportunities for market players.